Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo‐controlled, double‐blind phase I/Ib studies in healthy subjects and patients
Maurits F. J. M. Vissers, Jules A. A. C. Heuberger, Geert Jan Groeneveld, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 8, pp. 2010-2023
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases
Lian Wang, Yanghui Zhu, Lu Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 43
Role of necroptosis in kidney health and disease
Benedikt Kolbrink, Friedrich Alexander von Samson‐Himmelstjerna, James M. Murphy, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 5, pp. 300-314
Closed Access | Times Cited: 42
Regulated Necrosis in Atherosclerosis
Pauline Puylaert, Michelle Zurek, Katey J. Rayner, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 11, pp. 1283-1306
Open Access | Times Cited: 60
New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022
JingSi Jiang, Yan Wang, Min Deng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death
Jarama Clucas, Pascal Meier
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 11, pp. 835-852
Closed Access | Times Cited: 34
Targeting RIPK1 kinase for modulating inflammation in human diseases
Wanjin Li, Junying Yuan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 32
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 15
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
Xiangyuan Meng, Qi Song, Zinan Liu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 12
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
Kiterie M. E. Faller, Helena Chaytow, Thomas H. Gillingwater
Nature Reviews Neurology (2025) Vol. 21, Iss. 2, pp. 86-102
Closed Access | Times Cited: 1
Unlocking the therapeutic potential of protein kinase inhibitors in neurodegenerative and psychiatric disorders
A. V., Polina Buzaeva, Izhak Michaelevski
(2025) Vol. 2, Iss. 6
Open Access | Times Cited: 1
Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis
Matija Zelic, Anna S. Blazier, Fabrizio Pontarelli, et al.
Immunity (2025)
Open Access | Times Cited: 1
Kinases control of regulated cell death revealing druggable targets for Parkinson’s disease
Heba M. Mansour, Ahmed F. Mohamed, Aiman S. El‐Khatib, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101841-101841
Closed Access | Times Cited: 21
Protein phosphorylation and kinases: Potential therapeutic targets in necroptosis
Yihui Shi, Chengkun Wu, Jiayi Shi, et al.
European Journal of Pharmacology (2024) Vol. 970, pp. 176508-176508
Closed Access | Times Cited: 8
Necroptosis and Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Opportunities
Ruxin Zhang, Yanrong Song, Xuefeng Su
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S367-S386
Open Access | Times Cited: 24
Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer's disease
Sara Chavoshinezhad, Elmira Beirami, Esmael Izadpanah, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115656-115656
Open Access | Times Cited: 15
Necroptosis inhibitors: mechanisms of action and therapeutic potential
Yingbo Zhou, Zhangtao Cai, Yijia Zhai, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 22-44
Closed Access | Times Cited: 15
RIPK1 inhibitor ameliorates pulmonary injury by modulating the function of neutrophils and vascular endothelial cells
Tao Yang, Caigui Xiang, Xiaohan Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
The current and emerging Klotho-enhancement strategies
Haniyeh Poursistany, Solmaz Tabibi Azar, Mahsan Tabibi Azar, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 693, pp. 149357-149357
Closed Access | Times Cited: 11
Targeting necroptosis: a promising avenue for respiratory disease treatment
Xianya Cao, Junlan Tan, Runxiu Zheng, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Mechanism of microglia-mediated neuroinflammation, associated cognitive dysfunction, and therapeutic updates in Alzheimer's disease
Ashish Ghimire, Sayeed Ur Rehman, A. Subhani, et al.
hLife (2025)
Open Access
Safety, Pharmacokinetics and Target Engagement of a Novel Brain Penetrant RIPK1 Inhibitor (SIR9900) in Healthy Adults and Elderly Participants
Ofer M. Gonen, Tim Porter, Buwei Wang, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access
Discovery and Characterization of Novel Receptor-Interacting Protein Kinase 1 Inhibitors Using Deep Learning and Virtual Screening
Bo Liu, Likun Zhao, Ying Tan, et al.
ACS Chemical Neuroscience (2025)
Closed Access
The Role of Post-Translational Modifications in Necroptosis
Hao Xiao, Zang Chao Han, Min Xu, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 549-549
Open Access
Molecular and functional characteristics of receptor-interacting protein kinase 1 (RIPK1) and its therapeutic potential in Alzheimer's disease
Satyam Pati, Avtar Singh Gautam, Mangaldeep Dey, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103750-103750
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top